Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma-Reference-Cited by-同舟云学术

Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

Published:2017-09-25 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Cornelius Albert,Foley Jessica,Bond Jeffrey,Nagulapally Abhinav B.,Steinbrecher Julie,Hendricks William P. D.,Rich Maria,Yendrembam Sangeeta,Bergendahl Genevieve,Trent Jeffrey M.,Sholler Giselle S.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo;Alexandrova;Cell Death Dis.,2017

2. Which therapy works better in choroid plexus carcinomas?;Berrak;J. Neurooncol,2011

3. Treatment of choroid plexus tumors: a 20-year single institutional experience;Bettegowda;J. Neurosurg. Pediatr.,2012

4. Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience;Bezecny;Med. Oncol.,2014

5. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors;Brinster;Cell,1984

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progress;Neuro-Oncology Advances;2024-01-01

2. An Asymptomatic, Ectopic Mass as a Presentation of Adrenocortical Carcinoma Due to a Novel Germline TP53 p.Phe338Leu Tetramerisation Domain Variant;Children;2023-11-07

3. Approaches to Minimise the Neurodevelopmental Impact of Choroid Plexus Carcinoma and Its Treatment;Life;2023-09-01

4. Novel Adjuvant Targeted Approach for PTEN-Mutated Choroid Plexus Carcinoma in Adults: Case Report and Literature Review;JCO Precision Oncology;2023-08

5. Leptomeningeal dissemination in pediatric brain tumors;Neoplasia;2023-05